Dr. Hemenway is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2160 South First Avenue
Maywood, IL 60153Phone+1 708-327-3130Fax+1 708-327-3342- Is this information wrong?
Summary
- Dr. Charles Hemenway is a pediatric hematologist/oncologist in Maywood, IL. He received his medical degree from University of Massachusetts Medical School and has been in practice 30 years. He is experienced in general hematologic and oncologic diseases in children. His research focus is fusion oncogene proteins in childhood leukemia.
Education & Training
- Duke University HospitalFellowship, Pediatric Hematology/Oncology, 1991 - 1995
- University of Florida College of MedicineResidency, Internal Medicine/Pediatrics, 1987 - 1991
- University of Massachusetts Medical SchoolClass of 1987
Certifications & Licensure
- LA State Medical License 2022 - 2024
- IL State Medical License 2007 - 2023
- NC State Medical License 1995 - 1998
- FL State Medical License 1989 - 1994
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Re-examining a strong recommendation based on low-quality evidence in acute chest syndrome.Charles S Hemenway> ;Pediatric Blood & Cancer. 2023 May 1
- 1 citationsEmergence of a Ph-negative Clone in a Child With Ph+ ALLCasey J Mehrhoff, Charles S. Hemenway, Eugene Suh> ;Journal of Pediatric Hematology/oncology. 2020 Aug 1
- 78 citationsDegree of Recruitment of DOT1L to MLL-AF9 Defines Level of H3K79 Di- and Tri-methylation on Target Genes and Transformation PotentialAravinda Kuntimaddi, Nicholas J. Achille, Jeremy Thorpe, Alyson A. Lokken, Ritambhara Singh, Charles S. Hemenway, Mazhar Adli, Nancy J. Zeleznik-Le, John H. Bushweller> ;Cell Reports. 2015 May 5
- Join now to see all
Press Mentions
- Twenty-Seven Loyola Physicians Named to Chicago Magazine's 2019 Top Cancer DoctorsNovember 6th, 2019
Grant Support
- Structure/Function Of AF9 And MLL-AF9National Cancer Institute2011
- Targeted Therapy For 11Q23 Acute LeukemiasNational Cancer Institute2009–2011
- Disrupting The AF4-AF9 Protein Complex In MLL Leukemias.National Cancer Institute2008–2009
- Tulane Cancer Genetics Cobre: Inovative Therapies For T(4;11) LeukemiaNational Center For Research Resources2004–2008
- Targeted Therapy For 11Q23 Acute Leukemias.National Cancer Institute2004–2007
- BMI1 Interacting Proteins In Neoplastic TransformationNational Cancer Institute1999–2002
Professional Memberships
- Member
Hospital Affiliations
- Children's HospitalNew Orleans, Louisiana
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: